$NVS cardiovascular franchise showing its muscle: Both Entresto and Leqvio were characterized as very poor launches, now they are both major growth drivers
https://www.novartis.com/sites/novartis_com/files/q4-2024-investor-presentation.pdf
https://www.novartis.com/sites/novartis_com/files/q4-2024-investor-presentation.pdf
1 / 2
Comments